Literature DB >> 29315834

Medical safety in the care of the person with end-stage kidney disease.

John V Duronville1, Clarissa J Diamantidis1,2.   

Abstract

Much is written about medical safety as it pertains to patients with chronic kidney disease, yet the transition to end-stage kidney disease and processes inherent to the receipt of dialysis present unique safety challenges in this population. Educational efforts in medical safety need to focus on the areas of greatest threat and where intervention can provide the greatest benefit. This study addresses such safety topics in the dialysis population and identifies potential strategies that may aid in harm reduction.
© 2018 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29315834      PMCID： PMC5839985          DOI： 10.1111/sdi.12672

Source DB:  PubMed          Journal:  Semin Dial        ISSN： 0894-0959            Impact factor:   3.455


  87 in total

1.  Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons.

Authors:  Ronald L Pisoni; Lindsay Zepel; Friedrich K Port; Bruce M Robinson
Journal:  Am J Kidney Dis       Date:  2015-02-07       Impact factor: 8.860

2.  Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

3.  Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.

Authors:  Mitesh Shah; Meytal Avgil Tsadok; Cynthia A Jackevicius; Vidal Essebag; Mark J Eisenberg; Elham Rahme; Karin H Humphries; Jack V Tu; Hassan Behlouli; Helen Guo; Louise Pilote
Journal:  Circulation       Date:  2014-01-22       Impact factor: 29.690

4.  Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.

Authors:  Peter A McCullough; Timothy Ball; Katy Mathews Cox; Manish D Assar
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

5.  Iatrogenic Baclofen Neurotoxicity in ESRD: Recognition and Management.

Authors:  John K Roberts; Scott Westphal; Matthew A Sparks
Journal:  Semin Dial       Date:  2015-06-21       Impact factor: 3.455

Review 6.  Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis.

Authors:  Page Crew; Shannon J Heintz; Brett H Heintz
Journal:  Am J Health Syst Pharm       Date:  2015-11-01       Impact factor: 2.637

7.  Factors associated with the receipt of antimicrobials among chronic hemodialysis patients.

Authors:  Graham M Snyder; Priti R Patel; Alexander J Kallen; James A Strom; J Kevin Tucker; Erika M C D'Agata
Journal:  Am J Infect Control       Date:  2016-05-13       Impact factor: 2.918

8.  The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis.

Authors:  András Tislér; Katalin Akócsi; Béla Borbás; László Fazakas; Sándor Ferenczi; Sándor Görögh; Imre Kulcsár; Lajos Nagy; József Sámik; János Szegedi; Eszter Tóth; Gyula Wágner; István Kiss
Journal:  Nephrol Dial Transplant       Date:  2003-12       Impact factor: 5.992

Review 9.  Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.

Authors:  Jingwen Tan; Shuiqing Liu; Jodi B Segal; G Caleb Alexander; Mara McAdams-DeMarco
Journal:  BMC Nephrol       Date:  2016-10-21       Impact factor: 2.388

10.  Falls and Fall-Related Injuries among Community-Dwelling Adults in the United States.

Authors:  Santosh K Verma; Joanna L Willetts; Helen L Corns; Helen R Marucci-Wellman; David A Lombardi; Theodore K Courtney
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.